The present application discloses treatment of prostate cancer with anti-ErbB2 antibodies.

 
Web www.patentalert.com

< Bioceramic compositions

< Pyropheophorbides and their use in photodynamic therapy

> Enhanced in vitro synthesis of active proteins containing disulfide bonds

> Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
~ 00261